Steven Gelone
2021
In 2021, Steven Gelone earned a total compensation of $1.5M as President and Chief Operating Officer at Nabriva Therapeutics AG, a 34% increase compared to previous year.
Compensation breakdown
| Bonus | $225,000 |
|---|---|
| Non-Equity Incentive Plan | $191,590 |
| Salary | $500,947 |
| Stock Awards | $611,349 |
| Other | $14,138 |
| Total | $1,543,024 |
Gelone received $611.3K in stock awards, accounting for 40% of the total pay in 2021.
Gelone also received $225K in bonus, $191.6K in non-equity incentive plan, $500.9K in salary and $14.1K in other compensation.
Rankings
In 2021, Steven Gelone's compensation ranked 7,138th out of 12,406 executives tracked by ExecPay. In other words, Gelone earned more than 42.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,138 out of 12,406 | 43rd |
Division Manufacturing | 3,120 out of 5,494 | 43rd |
Major group Chemicals And Allied Products | 1,377 out of 2,369 | 42nd |
Industry group Drugs | 1,226 out of 2,090 | 41st |
Industry Pharmaceutical Preparations | 896 out of 1,537 | 42nd |
Source: SEC filing on July 11, 2022.
Gelone's colleagues
We found two more compensation records of executives who worked with Steven Gelone at Nabriva Therapeutics AG in 2021.